Study Investigates Effects of Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, on Postoperative Anemia and Inappropriate Blood Transfusion in Patients Undergoing Hip and Knee Surgery 
South Bend Clinic Invests Additional $5.6 Million in NextGen Healthcare Solutions to Improve Delivery of Value-Based Care 
NextGen Healthcare Acquires Topaz Information Solutions 
NextGen Healthcare, Inc. Reports Fiscal 2020 Second Quarter 
New Study Reveals Method Linking AMRA Medical’s Muscle Biomarkers and Function Choices Inc. to Partner with Streamline for SmartCare MCO/EHR Platform
OAKBROOK TERRACE, Ill.–(BUSINESS WIRE)–#EHR–Streamline Healthcare Solutions and Choices Inc. of Indianapolis, IN have entered into…
Medical Economics® Releases Exclusive Results of 2019 Electronic Health Records Scorecard
Survey results highlight a growing call among physicians for EHR vendors to improve the efficiency…
ImmersiveTouch Expands Availability of ImmersiveView™ Virtual Reality Solutions Into the Neurosurgery Market
ImmersiveTouch to expand commercial operations into neurosurgery market through co-marketing collaboration with Zimmer Biomet’s Craniomaxillofacial…
Survey: Gen X Leads the Charge on Digital Health Adoption
Americans cited privacy and security as top reason to avoid using mobile apps MADISON, Wis.–(BUSINESS…
Philips and the U.S. Department of Defense Develop Breakthrough Technology Using AI to Identify Infection More Than 48 Hours Before Observable Symptoms
Using large data sets & machine learning across biomarkers, innovative tech can speed time to…
Canland Health Announces Closing of Non-Brokered Private Placement
VANCOUVER, BC / ACCESSWIRE / October 22, 2019 / Canland Health Corp. (the “Company”) today…
Jaguar Health’s Study Shows Mytesi (Crofelemer) May Support Treatment of Diarrhea in Cancer Patients Receiving Targeted Therapy While Also Enabling Maintenance and Tolerability of a Higher Dose of the Selected TKI
SAN FRANCISCO, CA / ACCESSWIRE / October 22, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”…
Michèle C. Linde Promoted to EVP, Global Corporate Governance, Chief Legal Officer & Corporate Secretary for Virpax(R) Pharmaceuticals
MALVERN, PA / ACCESSWIRE / October 22, 2019 / Virpax® Pharmaceuticals, Inc. (“Virpax”), a company…
Oncolytics Biotech(R) and PrECOG Announce Collaboration for BRACELET-1 (PrE0113) Study in Metastatic Breast Cancer
Study seeks to confirm predictive and prognostic biomarkers demonstrating pelareorep can expand application of checkpoint…
Theralase Granted European Patent for Anti-Cancer Photo Dynamic Compounds
TORONTO, ONTARIO / ACCESSWIRE / October 22, 2019 / Theralase® Technologies Inc. (“Theralase” or the…